To determine the up-to-date trends in cancer screening, we have excluded hospital prostate cancer screening data from our analysis due to the wide practice of performing the prostate specific antigen (PSA) blood test outside of the hospital setting. The gene discussed is KLK3; the disease is prostate carcinoma.